Item 2.02 Results of Operations and Financial Condition
On
Item 7.01 Regulation FD Disclosure
Members of the Company's management team expect to make a presentation regarding
the Company (the "Presentation") to investors and analysts and to meet with
investors and analysts at the J.P. Morgan Annual Healthcare Conference between
The information in Items 2.02 and 7.01 and Exhibit 99.1 and of this Current Report on Form 8-K are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (Exchange Act), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (Securities Act). The information in Item 2.02 and this Item 7.01 and Exhibit 99.1 shall not be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release titled "Intersect ENT Reports Preliminary Full Year 2019 Revenue" datedJanuary 13, 2020 . 104 Cover Page Interactive Data File (formatted as inline XBRL)
--------------------------------------------------------------------------------
© Edgar Online, source